Who We Are BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions. Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered
Who We Are BioMarin’s Technical Operations group is responsible for creating our drugs for use in clinical trials and for scaling production of those drugs for the commercial market. These engineers, technicians, scientists and support staff
JLL empowers you to shape a brighter way. Our people at JLL are shaping the future of real estate for a better world by combining world class services, advisory and technology for our clients. We are
Who We Are BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions. Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered
Scientist, Synthetic Immune Cell Engineering SF Bay Area (Mid-Peninsula) Our client is an early-stage biotech startup pioneering a next-generation platform for engineered cell therapies. They are building a proprietary receptor architecture designed to unlock previously inaccessible
Shift Lead BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions. Guided by our purpose to develop medicines that make a profound impact on peoples lives, our global teams have delivered a
Endangered Species Act & Magnuson-Stevens Act Support Lynker Corporation is a leading provider of innovative solutions in weather and climate science. With a commitment to excellence and a passion for innovation, Lynker leverages cutting-edge technologies and
Company Description Axolabs is a business unit of LGC, and a leading provider of CRO / CDMO capability to the therapeutic oligonucleotide discovery and development industry. Centred out of LGC’s site in Kulmbach, Germany, Axolabs works